President Trump recently signed an order to speed up the evaluation of psychedelics to treat the brain. That’s coming after decades of strict prohibition on psychedelic drug use dating back to President Nixon. So how did we go from that to a psychedelic renaissance? A look into a key institution in the world of psychedelic research may give us some clues. This episode, NPR’s brain correspondent Jon Hamilton shares insight from a recent trip. (No pun intended.)
Want more psychedelic content? Catch our episode on ketamine therapy here, or learn why some scientists want to take the trip out of psychedelics here.
Have other questions about psychedelics and the brain? Let us know by emailing shortwave@npr.org!
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
NPR Privacy Policy

SHARE

COMMENT

VOICE_COMMENT

COMMENT_PAGE

CLAP

PICK

VOTE

AI_SUMMARIZE

New discoveries, everyday mysteries, and the science behind the headlines — in just under 15 minutes. It's science for everyone, using a lot of creativity and a little humor. Join hosts Emily Kwong and Regina Barber for science on a different wavelength.

If you're hooked, try Short Wave Plus. Your subscription supports the show and unlocks a sponsor-free feed. Learn more at plus.npr.org/shortwave

AI_SUMMARIZE_EPISODE

Short Wave

How science is taking tripping mainstream

5e75a544418a84a04631b31e/lvEAmBLnVX-25UOgkvv6tOq_jAzk.mp3